In a filing, AlloVir Inc revealed its insider Sinha Vikas unloaded Company’s shares for reported $1393.0 on Apr 22 ’24. In the deal valued at $0.75 per share,1,857 shares were sold. As a result of this transaction, Sinha Vikas now holds 1,138,096 shares worth roughly $0.9 million.
Then, Miller Edward sold 757 shares, generating $568 in total proceeds. Upon selling the shares at $0.75, the General Counsel now owns 223,227 shares.
Before that, Hagen Brett R sold 480 shares. AlloVir Inc shares valued at $360 were divested by the Chief Accounting Officer at a price of $0.75 per share. As a result of the transaction, Hagen Brett R now holds 77,619 shares, worth roughly $61319.01.
BofA Securities downgraded its AlloVir Inc [ALVR] rating to an Underperform from a a Buy in a research note published on December 26, 2023; the price target was decreased to $1 from $17. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who decreased its forecast for the stock in late December from “an Overweight” to “a Neutral”. Leerink Partners also remained covering ALVR and has decreased its forecast on December 22, 2023 with a “Market perform” recommendation from previously “an Outperform” rating. JP Morgan revised its rating on December 22, 2023. It rated ALVR as “an Underweight” which previously was an “an Overweight”.
Price Performance Review of ALVR
On Tuesday, AlloVir Inc [NASDAQ:ALVR] saw its stock jump 3.66% to $0.79. Over the last five days, the stock has gained 7.62%. AlloVir Inc shares have risen nearly 16.34% since the year began. Nevertheless, the stocks have fallen -79.46% over the past one year. While a 52-week high of $6.12 was reached on 04/01/24, a 52-week low of $0.62 was recorded on 01/04/24. SMA at 50 days reached $0.7387, while 200 days put it at $1.6906. A total of 0.28 million shares were traded, compared to the trading of 0.17 million shares in the previous session.
Levels Of Support And Resistance For ALVR Stock
The 24-hour chart illustrates a support level at 0.7589, which if violated will result in even more drops to 0.7270. On the upside, there is a resistance level at 0.8239. A further resistance level may holdings at 0.8570. The Relative Strength Index (RSI) on the 14-day chart is 58.54, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0136, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 28.58%. Stochastics %K at 62.80% indicates the stock is a holding.
The most recent change occurred on August 18, 2023 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $17 price target.
